Cargando...
Risperidone versus placebo for schizophrenia
BACKGROUND: Risperidone is the first new‐generation antipsychotic drug made available in the market in its generic form. OBJECTIVES: To determine the clinical effects, safety and cost‐effectiveness of risperidone compared with placebo for treating schizophrenia. SEARCH METHODS: On 19th October 2015,...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2016
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463908/ https://ncbi.nlm.nih.gov/pubmed/27977041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006918.pub3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|